Valsartan Prices, Trend, Chart, Demand, Market Analysis, News, Historical and Forecast Data Report 2026 Edition
Valsartan Price Trend, Index and Forecast
Track the latest insights on valsartan price trend and forecast with detailed analysis of regional fluctuations and market dynamics across North America, Latin America, Central Europe, Western Europe, Eastern Europe, Middle East, North Africa, West Africa, Central and Southern Africa, Central Asia, Southeast Asia, South Asia, East Asia, and Oceania.
Valsartan Prices Outlook Q2 2026
- USA: USD 87692/MT
- Germany: USD 89817/MT
- India: USD 78215/MT
- Brazil: USD 83927/MT
- Canada: USD 89381/MT
Valsartan Price Chart
Get real-time access to monthly/quaterly/yearly prices, Request Sample
During the second quarter of 2026, the valsartan prices in the USA reached 87692 USD/MT in June. Prices increased as tighter import availability reduced the volume of immediately accessible material for domestic buyers. Extended nitrosamine testing slowed batch releases from overseas suppliers and lengthened procurement lead times. Importers responded by rebuilding safety stocks and advancing purchases, which strengthened supplier bargaining power.
During the second quarter of 2026, the valsartan prices in Germany reached 89817 USD/MT in June. Prices moved upward as European buyers faced tighter prompt availability from Asian suppliers, particularly when exportable volumes from India became less readily available. Longer release cycles from suppliers further restricted near term cargo availability and encouraged buyers to secure material earlier. German pharmaceutical purchasers also increased procurement ahead of scheduled tender activity, which improved spot demand and supported firmer offers.
During the second quarter of 2026, the valsartan prices in India reached 78215 USD/MT in June. Prices declined slightly as additional domestic supply entered the market and competition among producers intensified. Regular plant operating schedules kept material availability comfortable, allowing formulation buyers to negotiate more actively and avoid urgent purchases. Domestic offtake remained steady, but it was not strong enough to absorb all available spot material at firmer offer levels.
During the second quarter of 2026, the valsartan prices in Brazil reached 83927 USD/MT in June. Prices increased as buyers remained dependent on imported active pharmaceutical ingredients and faced higher replacement costs from overseas suppliers. Firmer export quotations reduced the availability of lower cost offers, while longer shipping routes and geopolitical freight disruptions raised landed cost pressure. Importers also had to maintain compliant sourcing and documentation standards for pharmaceutical ingredients, limiting rapid substitution toward unqualified suppliers when preferred cargoes became tighter.
During the second quarter of 2026, the valsartan prices in Canada reached 89381 USD/MT in June. Prices rose as buyers faced the same tighter North American import environment affecting pharmaceutical active ingredients sourced from Asia. Extended quality testing and slower batch release schedules reduced prompt availability and lengthened replenishment cycles for approved material. Importers responded by increasing safety stock coverage and placing orders earlier to reduce exposure to delivery uncertainty.
Valsartan Prices Outlook Q1 2026
- USA: USD 81779/MT
- Germany: USD 83345/MT
- India: USD 79101/MT
- Brazil: USD 79506/MT
- Canada: USD 84266/MT
During the first quarter of 2026, the valsartan prices in the USA reached 81779 USD/MT in March. Prices moved lower as buyers maintained cautious procurement and avoided excess inventory buildup. Demand from formulation manufacturers remained steady, yet purchasing activity was mostly need based due to adequate stock availability across the supply chain. Import availability also improved, which reduced urgency among downstream buyers and placed pressure on offers.
During the first quarter of 2026, the valsartan prices in Germany reached 83345 USD/MT in March. The market recorded a downward trend as pharmaceutical buyers continued to manage inventories carefully after earlier procurement cycles. Demand from generic drug manufacturers remained present, but fresh purchasing was measured due to sufficient material availability. Suppliers faced pressure to revise offers as buyers negotiated actively amid softer market sentiment.
During the first quarter of 2026, the valsartan prices in India reached 79101 USD/MT in March. Prices declined as domestic buyers reduced spot purchases and relied on existing inventory. Demand from formulation units remained stable, yet procurement was selective because buyers expected softer replacement costs. Local supply conditions were adequate, and sellers competed to secure orders in a slower trading environment. Export inquiries were also moderate, which limited support for higher offers.
During the first quarter of 2026, the valsartan prices in Brazil reached 79506 USD/MT in March. The market followed a downward movement as importers and distributors avoided heavy stock accumulation. Demand from pharmaceutical formulators continued, but buyers remained price sensitive and placed orders mainly against confirmed requirements. Availability through import channels improved, reducing supply concerns and limiting the ability of sellers to maintain stronger quotations.
During the first quarter of 2026, the valsartan prices in Canada reached 84266 USD/MT in March. Prices declined as downstream buyers maintained disciplined purchasing and avoided aggressive restocking. Pharmaceutical demand remained consistent, supported by ongoing requirements from generic medicine production, yet buyers held back from large volume commitments. Supply availability stayed comfortable, with importers reporting stable material access. Sellers faced resistance from customers who expected softer offers after the previous quarter.
Valsartan Prices Outlook Q2 2025
- USA: USD 90660/MT
- Germany: USD 92700/MT
- India: USD 86240/MT
- Brazil: USD 87600/MT
Regional Coverage
The report provides a detailed analysis of the market across different regions, each with unique pricing dynamics influenced by localized market conditions, supply chain intricacies, and geopolitical factors. This includes price trends, price forecast and supply and demand trends for each region, along with spot prices by major ports. The report also provides coverage of FOB and CIF prices, as well as the key factors influencing valsartan prices.
Europe Valsartan Price Trend
Q2 2026:
The valsartan price index in Europe strengthened as buyers encountered tighter import availability and firmer replacement costs. Reduced export flexibility from major Asian suppliers limited prompt cargo options, especially for purchasers requiring qualified pharmaceutical grade material. Longer supplier release cycles and additional impurity control requirements also raised compliance related production costs at origin. European formulation companies maintained steady procurement for antihypertensive products, and some buyers advanced orders ahead of tender schedules to secure supply continuity. Shipping rerouting associated with geopolitical tensions extended transit times and increased freight exposure for imported APIs.
Q1 2026:
The valsartan price index in Europe moved lower as regional buyers maintained cautious procurement and avoided excess inventory. Pharmaceutical manufacturers continued routine production of antihypertensive formulations, but demand remained largely contract based rather than spot driven. Germany reflected this softer tone, with buyers negotiating from a stronger position due to stable import availability and adequate local distribution stocks. Approved suppliers from Asia continued to offer competitive material, which pressured European price levels.
This analysis can be extended to include detailed valsartan price information for a comprehensive list of countries.
| Region | Countries Covered |
|---|---|
| Europe | Germany, France, United Kingdom, Italy, Spain, Russia, Turkey, Netherlands, Poland, Sweden, Belgium, Austria, Ireland, Switzerland, Norway, Denmark, Romania, Finland, Czech Republic, Portugal, and Greece, among other European countries. |
North America Valsartan Price Trend
Q2 2026:
The valsartan price index in North America moved upward as importers faced tighter access to approved overseas supply. Extended nitrosamine testing and slower batch release procedures delayed the movement of some Asian material into the region, reducing immediate availability for buyers. Importers and distributors increased safety stock coverage and advanced procurement schedules to limit exposure to delivery uncertainty. This purchasing behavior strengthened seller leverage even though routine consumption from generic formulation and hospital channels remained broadly stable. Geopolitical shipping disruptions forced some cargoes onto longer routes, increasing transit complexity and landed cost pressure. Supplier pacing also reduced the number of competitively offered spot parcels available for rapid delivery.
Q1 2026:
The valsartan price index in North America declined, with the USA and Canada both showing weaker pricing compared with the previous quarter. Demand from generic pharmaceutical producers remained stable, but procurement teams focused on inventory control and cost optimization. Buyers showed limited interest in large volume spot purchases as supply availability remained comfortable. Import channels remained reliable, reducing concerns over shortage driven premiums. Competitive offers from approved overseas suppliers also encouraged lower contract discussions.
Specific valsartan historical data within the United States and Canada can also be provided.
| Region | Countries Covered |
|---|---|
| North America | United States and Canada |
Middle East and Africa Valsartan Price Trend
Q2 2026:
The study includes valsartan price patterns across the Middle East and Africa, taking into consideration variables that have a direct impact on market prices, such as regional industrial expansion, natural resource availability, and geopolitical conflicts.
Q1 2026:
According to the valsartan price chart, prices in the Middle East and Africa exhibited fluctuations due to a combination of factors, mainly influenced by supply chain disruptions, changing seasonal demand patterns, and ongoing geopolitical developments.
In addition to region-wise data, information on valsartan prices for countries can also be provided.
| Region | Countries Covered |
|---|---|
| Middle East & Africa | Saudi Arabia, UAE, Israel, Iran, South Africa, Nigeria, Oman, Kuwait, Qatar, Iraq, Egypt, Algeria, and Morocco, among other Middle Eastern and African countries. |
Asia Pacific Valsartan Price Trend
Q2 2026:
Valsartan prices in Asia Pacific moved downward as improved supply availability and stronger competition among regional producers weakened seller leverage. Indian manufacturers maintained steady operating rates, which increased the volume of material available for domestic and export markets. Buyers also adopted cautious purchasing strategies and focused on immediate requirements rather than building large inventories. Sufficient stock levels across key consuming markets reduced urgency for fresh procurement and encouraged purchasers to negotiate lower offers. Competition among suppliers intensified as producers sought to secure export orders and maintain plant utilization. Stable availability of key raw materials further prevented significant production cost escalation during the quarter.
Q1 2026:
In the Asia Pacific, valsartan prices weakened as regional supply remained sufficient and buyers maintained selective procurement. India reflected a softer market tone as producers faced moderate domestic demand and competitive export conditions. Manufacturing activity remained steady, but formulation companies avoided aggressive raw material accumulation. Supplier competition across major producing countries placed downward pressure on offers, especially for buyers placing repeat orders. Availability of intermediates remained stable, allowing producers to maintain output without major disruption.
This valsartan price analysis can be expanded to include a comprehensive list of countries within the region.
| Region | Countries Covered |
|---|---|
| Asia Pacific | China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Thailand, South Korea, Malaysia, Nepal, Taiwan, Sri Lanka, Hongkong, Singapore, Australia, and New Zealand, among other Asian countries. |
Latin America Valsartan Price Trend
Q2 2026:
The valsartan market in Latin America is primarily driven by the region's abundant natural resources, particularly in Chile and Brazil. However, due to political instability and varying regulatory regimes, valsartan prices might fluctuate dramatically.
Q1 2026:
The market for valsartan in Latin America is primarily driven by the region's abundant natural resources, especially in nations like Chile and Brazil. However, pricing for valsartan can fluctuate significantly due to political unpredictability and varied regulatory regimes.
This comprehensive review can be extended to include specific countries within the region.
| Region | Countries Covered |
|---|---|
| Latin America | Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru, among other Latin American countries. |
Valsartan Pricing Report, Market Analysis, and News
IMARC's latest publication, “Valsartan Prices, Trend, Chart, Demand, Market Analysis, News, Historical and Forecast Data Report 2026 Edition,” presents a detailed examination of the valsartan market, providing insights into both global and regional trends that are shaping prices. This report delves into the spot price of valsartan at major ports and analyzes the composition of prices, including FOB and CIF terms. It also presents detailed valsartan prices trend analysis by region, covering North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. The factors affecting valsartan pricing, such as the dynamics of supply and demand, geopolitical influences, and sector specific developments, are thoroughly explored. This comprehensive report helps stakeholders stay informed with the latest market news, regulatory updates, and technological progress, facilitating informed strategic decision-making and forecasting.
Valsartan Industry Analysis
The global valsartan industry size reached USD 5.6 Billion in 2025. By 2034, IMARC Group expects the market to reach USD 8.3 Billion, at a projected CAGR of 4.42% during 2026-2034. Market growth is driven by rising demand for hypertension treatment, expanding generic drug production, and wider access to cardiovascular therapies.
Latest News and Developments:
- January 2026: Sacubitril/valsartan showed encouraging benefits for patients with advanced CKD or ESRD and heart failure with reduced ejection fraction. In a review of ten observational studies covering 4329 adults, the therapy was linked to improved left ventricular ejection fraction and lower systolic blood pressure in ESRD patients. Researchers also reported no increased risk of hyperkalemia or hypotension, supporting its potential safety in this high risk group. Larger randomized trials are expected to further confirm these positive findings.
Product Description
Valsartan is a small molecule active pharmaceutical ingredient used in medicines for hypertension, heart failure, and certain patients following myocardial infarction. Its molecular formula is C24H29N5O3, and it belongs to the angiotensin II receptor blocker class. The compound is generally supplied as a white or nearly white powder and is only slightly soluble in water. It shows greater solubility in selected alkaline and organic media. Pharmacologically, valsartan selectively blocks angiotensin II activity at the AT1 receptor, reducing vasoconstriction and aldosterone related effects that contribute to elevated blood pressure and cardiac workload. Industrially, valsartan is manufactured as a pharmaceutical grade API for tablets, capsules, oral solutions, and combination medicines.
Report Coverage
| Key Attributes | Details |
|---|---|
| Product Name | Valsartan |
| Report Features | Exploration of Historical Trends and Market Outlook, Industry Demand, Industry Supply, Gap Analysis, Challenges, Valsartan Price Analysis, and Segment-Wise Assessment. |
| Currency/Units | US$ (Data can also be provided in local currency) or Metric Tons |
| Region/Countries Covered | The current coverage includes analysis at the global and regional levels only. Based on your requirements, we can also customize the report and provide specific information for the following countries: Asia Pacific: China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Thailand, South Korea, Malaysia, Nepal, Taiwan, Sri Lanka, Hongkong, Singapore, Australia, and New Zealand Europe: Germany, France, United Kingdom, Italy, Spain, Russia, Turkey, Netherlands, Poland, Sweden, Belgium, Austria, Ireland, Switzerland, Norway, Denmark, Romania, Finland, Czech Republic, Portugal and Greece North America: United States and Canada Latin America: Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru Middle East & Africa: Saudi Arabia, UAE, Israel, Iran, South Africa, Nigeria, Oman, Kuwait, Qatar, Iraq, Egypt, Algeria, and Morocco The list of countries presented is not exhaustive. Information on additional countries can be provided if required by the client. |
| Information Covered for Key Suppliers |
|
| Customization Scope | The report can be customized as per the requirements of the customer |
| Report Price and Purchase Option |
Plan A: Monthly Updates - Annual Subscription
Plan B: Quarterly Updates - Annual Subscription
Plan C: Biannually Updates - Annual Subscription
|
| Post-Sale Analyst Support | 360-degree analyst support after report delivery |
| Delivery Format | PDF and Excel through email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Benefits for Stakeholders:
- IMARC’s report presents a detailed analysis of valsartan pricing, covering global and regional trends, spot prices at key ports, and a breakdown of Ex Works, FOB, and CIF prices.
- The study examines factors affecting valsartan price trend, including raw material costs, supply-demand shifts, geopolitical impacts, and industry developments, offering insights for informed decision-making.
- The competitive landscape review equips stakeholders with crucial insights into the latest market news, regulatory changes, and technological advancements, ensuring a well-rounded, strategic overview for forecasting and planning.
- IMARC offers various subscription options, including monthly, quarterly, and biannual updates, allowing clients to stay informed with the latest market trends, ongoing developments, and comprehensive market insights. The valsartan price charts ensure our clients remain at the forefront of the industry.
Need more help?
- Speak to our experienced analysts for insights on the current market scenarios.
- Include additional segments and countries to customize the report as per your requirement.
- Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
- For further assistance, please connect with our analysts.
Request Customization
Inquire Before Buying
Speak to an Analyst
Request Brochure
Benefits of Customization
- Personalize this research
- Triangulate with your data
- Get data as per your format and definition
- Gain a deeper dive into a specific application, geography, customer, or competitor
- Any level of personalization
Get in Touch With Us
UNITED STATES
Phone: +1-201-971-6302
INDIA
Phone: +91-120-433-0800
UNITED KINGDOM
Phone: +44-753-714-6104
Email: [email protected]
Client Testimonials
.webp)
.webp){kind=logo}
Related Reports
Why Choose Us
IMARC offers trustworthy, data-centric insights into commodity pricing and evolving market trends, enabling businesses to make well-informed decisions in areas such as procurement, strategic planning, and investments. With in-depth knowledge spanning more than 1000 commodities and a vast global presence in over 150 countries, we provide tailored, actionable intelligence designed to meet the specific needs of diverse industries and markets.
1000
+Commodities
150
+Countries Covered
3000
+Clients
20
+Industry
Robust Methodologies & Extensive Resources
IMARC delivers precise commodity pricing insights using proven methodologies and a wealth of data to support strategic decision-making.
Subscription-Based Databases
Our extensive databases provide detailed commodity pricing, import-export trade statistics, and shipment-level tracking for comprehensive market analysis.
Primary Research-Driven Insights
Through direct supplier surveys and expert interviews, we gather real-time market data to enhance pricing accuracy and trend forecasting.
Extensive Secondary Research
We analyze industry reports, trade publications, and market studies to offer tailored intelligence and actionable commodity market insights.
Trusted by 3000+ industry leaders worldwide to drive data-backed decisions. From global manufacturers to government agencies, our clients rely on us for accurate pricing, deep market intelligence, and forward-looking insights.